Equities research analysts expect that MINDBODY, Inc. (NASDAQ:MB) will post sales of $44.21 million for the current quarter, Zacks reports. Five analysts have issued estimates for MINDBODY’s earnings. The lowest sales estimate is $43.80 million and the highest is $44.80 million. MINDBODY posted sales of $33.56 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 31.7%. The business is expected to announce its next earnings report on Wednesday, July 26th.

According to Zacks, analysts expect that MINDBODY will report full year sales of $44.21 million for the current financial year, with estimates ranging from $179.63 million to $182.00 million. For the next financial year, analysts forecast that the company will post sales of $224.33 million per share, with estimates ranging from $218.77 million to $228.90 million. Zacks’ sales calculations are a mean average based on a survey of research firms that follow MINDBODY.

MINDBODY (NASDAQ:MB) last issued its earnings results on Thursday, May 4th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.02. The business had revenue of $42.20 million during the quarter, compared to analysts’ expectations of $42.09 million. MINDBODY had a negative net margin of 13.60% and a negative return on equity of 19.36%. The business’s revenue for the quarter was up 31.9% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.12) earnings per share.

MB has been the topic of several research reports. Roth Capital set a $32.00 price target on shares of MINDBODY and gave the stock a “buy” rating in a report on Tuesday, June 6th. BidaskClub cut shares of MINDBODY from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. Morgan Stanley raised their price objective on shares of MINDBODY from $27.00 to $29.00 and gave the stock an “equal weight” rating in a research note on Friday, May 5th. Zacks Investment Research raised shares of MINDBODY from a “sell” rating to a “hold” rating in a research note on Friday, May 19th. Finally, Credit Suisse Group raised their price objective on shares of MINDBODY from $27.00 to $31.00 and gave the stock an “outperform” rating in a research note on Friday, May 5th. Two investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $28.60.

ILLEGAL ACTIVITY NOTICE: This report was first published by Financial Market News and is the property of of Financial Market News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.financial-market-news.com/2017/06/17/zacks-analysts-anticipate-mindbody-inc-mb-will-announce-quarterly-sales-of-44-21-million.html.

MINDBODY (NASDAQ:MB) opened at 27.85 on Friday. MINDBODY has a one year low of $13.75 and a one year high of $29.75. The firm has a 50-day moving average of $27.63 and a 200 day moving average of $25.60. The stock’s market capitalization is $1.14 billion.

In related news, major shareholder Luxor Capital Group, Lp purchased 469,973 shares of MINDBODY stock in a transaction dated Friday, May 5th. The shares were acquired at an average price of $25.46 per share, for a total transaction of $11,965,512.58. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Richard Lee Stollmeyer sold 17,739 shares of MINDBODY stock in a transaction on Monday, April 3rd. The stock was sold at an average price of $27.26, for a total value of $483,565.14. The disclosure for this sale can be found here. In the last 90 days, insiders acquired 1,096,818 shares of company stock worth $29,426,735 and sold 63,543 shares worth $1,752,075. Company insiders own 30.62% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Quantbot Technologies LP raised its stake in shares of MINDBODY by 96.3% in the first quarter. Quantbot Technologies LP now owns 3,932 shares of the technology company’s stock valued at $107,000 after buying an additional 1,929 shares during the period. Legal & General Group Plc raised its stake in shares of MINDBODY by 4.1% in the first quarter. Legal & General Group Plc now owns 4,218 shares of the technology company’s stock valued at $116,000 after buying an additional 166 shares during the period. Credit Suisse AG bought a new stake in shares of MINDBODY during the first quarter valued at about $220,000. American International Group Inc. raised its stake in shares of MINDBODY by 7.1% in the first quarter. American International Group Inc. now owns 8,871 shares of the technology company’s stock valued at $244,000 after buying an additional 588 shares during the period. Finally, Tudor Investment Corp ET AL bought a new stake in shares of MINDBODY during the first quarter valued at about $311,000. Institutional investors and hedge funds own 77.21% of the company’s stock.

About MINDBODY

MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.

Get a free copy of the Zacks research report on MINDBODY (MB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for MINDBODY Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY Inc. and related companies with MarketBeat.com's FREE daily email newsletter.